This content is machine translated Breast Cancer EPIC study – a tumor rarely comes alone For eleven years, scientists had followed a large cohort of breast cancer patients from the so-called EPIC study (European Prospective Investigation Into Cancer And Nutrition). The aim was to determine…
View Post 3 min This content is machine translated Myelodysplastic syndromes (MDS) Are gas station attendants at increased risk for MDS? The biennial International Symposium on Myelodysplastic Syndromes (MDS) was held in Washington, USA, in early May. Risk factors for MDS were among the topics discussed. Several studies were presented in…
View Post 4 min This content is machine translated Chronic myeloid leukemia Diagnostics and therapy of CML – current state of knowledge A lot has happened in the field of chronic myeloid leukemia (CML) in recent years. Response and survival rates have risen sharply, and some patients are even said to be…
View Post 8 min This content is machine translated Current overview of sarcoma treatment Therapy options for sarcomas Sarcomas are rare malignant connective tissue tumors. Therapy is multidisciplinary and should be performed at sarcoma centers. In Switzerland, all sarcoma disciplines have organized themselves on a national level (www.sarcoma.ch).…
View Post 3 min This content is machine translated Advanced melanoma Pembrolizumab is superior to ipilimumab There is news on the KEYNOTE-006 study evaluating pembrolizumab (Keytruda®) for the treatment of advanced melanoma. The study was terminated early after the defined endpoints consisting of progression-free and overall…
View Post 2 min This content is machine translated Psychological problems with cancer The impact on patient and family is enormous Cancer diseases repeatedly bring patients and their relatives to their psychological limits. To prevent individuals from harming themselves or their children from developing behavioral problems, it is essential to identify…
View Post 4 min This content is machine translated Gastrointestinal Cancers Symposium 2015 Advanced colorectal cancer – first and second line news. Two studies presented at the 2015 Gastrointestinal Cancers Symposium in San Francisco were dedicated to first- and second-line treatment of metastatic colorectal cancer. One was to determine whether the more…
View Post 3 min This content is machine translated Prostate cancer risk Bald or not, varied sex life is crucial Epidemiological studies on the association between androgenetic alopecia and risk of prostate cancer are conflicting. Now it has been shown again: Male hair loss is unsuitable as a risk marker.…
View Post 5 min This content is machine translated The more drugs, the higher the risk Drug interactions in oncology In bright sunny early spring weather, it was hard to stay in the lightless lecture halls at the 25th Physicians’ Continuing Education Course in Clinical Oncology in St. Gallen, but…
View Post 6 min This content is machine translated Molecular markers are becoming increasingly important Treatment options for higher grade gliomas Histology (tumor resection or biopsy) is essential for diagnosis and evaluation of prognosis and therapy in higher grade gliomas. Molecular markers serve as an adjunct to WHO classification regarding expected…
View Post 7 min This content is machine translated Active surveillance as a treatment option Status quo and challenges using the example of prostate carcinoma Studies suggest that Active Surveillance is a treatment option for tumors with low risk of progression (low-risk tumors). The treatment team should work with the patient to determine treatment strategies…
